| U.S. Brand Names |
| Histolyn-CYL® Injection |
 |
| Generic Available |
|
No |
|
| Synonyms |
| Histoplasmosis Skin Test Antigen |
|
| Pharmacological Index |
|
Diagnostic Agent |
|
| Use |
|
Diagnosing histoplasmosis; to assess cell-mediated immunity |
|
| Pregnancy Risk Factor |
|
C |
|
| Adverse Reactions |
|
1% to 10%: Local: Ulceration or necrosis may occur at test site Respiratory: Dyspnea |
|
| Stability |
|
Store in refrigerator |
|
| Usual Dosage |
|
Adults: Intradermally: 0.1 mL of 1:100 dilution into volar surface of forearm; induration of greater than or equal to 5 mm in diameter indicates a positive reaction |
|
| Administration |
|
Use a 3/8 " to 1/2 " 26- or 27-gauge needle |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
Test must be read at 24-48 hours or 48-72 hours |
|
| Nursing Implications |
|
Examine reaction site at 24-48 hours for cell-mediated immunity and 48-72 hours for histoplasmosis; use a 3/8 " to 1/2 " 26- or 27-gauge needle |
|
| Dosage Forms |
|
Injection: 1:100 (0.1 mL, 1.3 mL) |
|
|
Copyright © 2007 Drugs Area |
